Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Tarsus Pharmaceuticals, Inc. (TARS) had Current Ratio of 4.42 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$182.95M |
|
$-115.55M |
|
$12.83M |
|
$170.13M |
|
$303.52M |
|
$-120.57M |
|
$5.01M |
|
$-115.55M |
|
$-115.55M |
|
$-115.55M |
|
$-115.55M |
|
$-115.55M |
|
$-115.55M |
|
$-120.57M |
|
$-123.08M |
|
37.60M |
|
37.60M |
|
$-3.07 |
|
$-3.07 |
|
| Balance Sheet Financials | |
$356.70M |
|
$2.31M |
|
$20.29M |
|
$376.99M |
|
$80.61M |
|
$71.84M |
|
$71.84M |
|
$152.46M |
|
$224.53M |
|
$216.21M |
|
$224.53M |
|
38.35M |
|
| Cash Flow Statement Financials | |
$-83.03M |
|
$-199.19M |
|
$154.66M |
|
$224.95M |
|
$97.38M |
|
$-127.57M |
|
$27.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
4.42 |
-- |
|
-- |
|
0.24 |
|
0.32 |
|
92.99% |
|
-65.90% |
|
-65.90% |
|
-67.27% |
|
-63.16% |
|
-63.16% |
|
$-84.59M |
|
-- |
|
-- |
|
-- |
|
0.49 |
|
4.90 |
|
3.81 |
|
95.88 |
|
-51.46% |
|
-53.45% |
|
-30.65% |
|
-38.99% |
|
$5.85 |
|
$-2.25 |
|
$-2.21 |
|